Invention Grant
US08481503B2 Combination cancer therapy with an AKT inhibitor and other anticancer agents
有权
联合癌症治疗与AKT抑制剂和其他抗癌剂
- Patent Title: Combination cancer therapy with an AKT inhibitor and other anticancer agents
- Patent Title (中): 联合癌症治疗与AKT抑制剂和其他抗癌剂
-
Application No.: US13254108Application Date: 2010-02-23
-
Publication No.: US08481503B2Publication Date: 2013-07-09
- Inventor: Mark E. Layton , Hiroshi Hirai , Hidehito Kotani
- Applicant: Mark E. Layton , Hiroshi Hirai , Hidehito Kotani
- Applicant Address: US NJ Rahway JP Chiyoda-Ku, Tokyo
- Assignee: Merck Sharp & Dohme Corp.,MSD K.K.
- Current Assignee: Merck Sharp & Dohme Corp.,MSD K.K.
- Current Assignee Address: US NJ Rahway JP Chiyoda-Ku, Tokyo
- Agent Yong Zhao; David A. Muthard; Matthew A. Leff
- International Application: PCT/US2010/025028 WO 20100223
- International Announcement: WO2010/101734 WO 20100910
- Main IPC: A01N43/04
- IPC: A01N43/04 ; A61K31/70
Abstract:
The invention relates to combination anticancer therapy with certain Akt inhibitor and other anticancer agents such as anticancer antimetabolites, anticancer antibiotics, plant-derived anticancer agents, anticancer platinum-coordinated complex compounds, anticancer camptothecin derivatives and anticancer tyrosine kinase inhibitors.
Public/Granted literature
- US20110319354A1 Combination Cancer Therapy with an AKT Inhibitor and Other Anticancer Agents Public/Granted day:2011-12-29
Information query
IPC分类:
